NAPLES, Fla. and MUMBAI, India, Feb. 26, 2026 /PRNewswire/ — Global pharmaceutical chief, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), immediately introduced that CEO Vinita Gupta was acknowledged on the CNBC Changemakers list of Women Transforming Business. Each yr, this prestigious record honors feminine leaders who’re redefining industries, breaking obstacles, and driving lasting change throughout numerous enterprise sectors.
“I am honored to be recognized as a CNBC Changemaker and listed amongst such extraordinary leaders who are driving significant change and impact,” mentioned Vinita Gupta, CEO, Lupin. “This recognition reflects not only my own journey, but the shared dedication of everyone at Lupin who works each day to help transform hope into healing. I truly believe that meaningful change occurs when purpose is matched by execution. I extend my congratulations to all the other honorees.”
Vinita constructed Lupin’s U.S. enterprise from the floor up. During her tenure as CEO, the firm grew into the third-largest generic drugs provider to the U.S. and the world’s seventh-largest pharmaceutical firm by quantity. Under her management, Lupin continues to increase its affect on reasonably priced drugs, complicated generics, inhalation and biosimilars. In late 2025, Lupin gained FDA approval for its first biosimilar Pegfilgrastim, marking a pivotal step in Lupin’s ongoing dedication to offering high-quality, reasonably priced medicines to U.S. sufferers.
Vinita has made growth in the U.S. a core pillar of Lupin’s worldwide development technique. In 2025, she superior efforts to strengthen home pharmaceutical manufacturing by progressing Lupin’s reshoring initiative and saying plans for a brand new state-of-the-art inhalation facility in Coral Springs, Florida. The website is anticipated to produce a number of respiratory merchandise, together with Albuterol. By increasing manufacturing in the United States, Lupin is reinforcing drugs safety and bettering affected person entry to important medicines.
CNBC Changemakers is an annual record spotlighting ladies whose accomplishments have left an indelible mark on the enterprise world. The record acknowledges feminine leaders who’re discovering options, driving innovation, and constructing companies poised for sustainable success.
Those acknowledged in the CNBC Changemakers record will probably be honored at the CNBC Changemakers Summit on April 16th in New York.
About Lupin
Lupin Limited is a world pharmaceutical chief headquartered in Mumbai, India, with merchandise distributed in over 100 markets. Lupin focuses on pharmaceutical merchandise, together with branded and generic formulations, complicated generics, biotechnology merchandise, and energetic pharmaceutical elements. Trusted by healthcare professionals and customers globally, the firm enjoys a powerful place in India and the U.S. throughout a number of remedy areas, together with respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and ladies’s well being. Lupin has 15 state-of-the-art manufacturing websites and 7 analysis facilities globally, together with a devoted workforce of over 24,000 professionals. Lupin is dedicated to bettering affected person well being outcomes via its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.